Navigation Links
Ferring Celebrates Winner of 2008 My Little Miracle Essay Contest During National Infertility Awareness Week

Contest Brings Hope and Awareness to Millions of Couples Struggling With Infertility

PARSIPPANY, N.J., Oct. 23 /PRNewswire/ -- Ferring Pharmaceuticals is honoring 12 lucky families who won the national 2008 My Little Miracle Essay Contest for their heart-warming and inspirational stories of their journey to parenthood. The winners' 'little miracles' were born with the help of Ferring's family of fertility products. The fifth annual contest celebrates the birth of children who were conceived using Ferring's MENOPUR(R) (menotropins for injection, USP) and/or BRAVELLE(R) (urofollitropin for injection, purified).

The grand prize winner, Sara Braunschweig of Delano, MN will receive $10,000 for an education fund for her six-month-old daughter, Ella, conceived after complications from her husband's vasectomy reversal. Despite many challenges, and being told by a physician that having a child wasn't possible, the couple was determined not to accept "no" for an answer. Thanks to the wonder of fertility treatments, Sara and her husband Michael are the proud parents of a 'little miracle.'

"Each story that we received conveyed a true message of hope and inspiration," said Wayne Anderson, president, Ferring Pharmaceuticals. "We are delighted that our treatments played a role in Sara and Michael's success and hope that more couples will be inspired by their story. With National Infertility Awareness Week upon us, we are focusing our attention on the millions of couples who are struggling to build a family and encourage them to never give up their dream of achieving parenthood."

"My husband and I were elated to learn that we were the grand prize winner of this year's My Little Miracle essay contest," said Sara. "We hope that families who are struggling to conceive will read our story and learn that there is hope. I am truly blessed to have a child and now we have a head start on her education, thanks to this wonderful program from Ferring."

Sara Braunschweig's Story

Sara's story begins as a teenager entering college with a message from her father: be confident in yourself; live your life mentally, physically and spiritually balanced; and seek joy. The later message, seek joy, was the resounding piece of advice that has stayed with Sara during the past 17 years. After graduating college and spending years climbing up the corporate ladder and earning good money, Sara realized that all of this meant nothing if she didn't have anyone to share it with. After cultivating a friendship and bond with her co-worker, Michael, it evolved into something more and eventually, marriage. Immediately after marrying, they started to try for a baby. The only catch was that Michael had had a vasectomy at the young age of 26. Determined to have a family, Michael underwent a vasectomy reversal and the couple immediately started trying to have a baby. Unfortunately, as months passed, Sara and Michael were not achieving a pregnancy. After consulting with the doctor, Sara and Michael asked the obvious question, "So how can we have kids?" The doctor looked at them and said, "You can't, adopt." Since this was an unacceptable answer to Sara and Michael, they sought the help of the physicians at Reproductive Medicine and Infertility Associates (RMIA) in Woodbury, MN. With the help of the medical team at RMIA, Sara decided to undergo in vitro fertilization (IVF) treatment and was prescribed BRAVELLE and MENOPUR and responded beautifully to the medications. After conceiving on the very first transfer, Sara and Michael welcomed their daughter Ella into their family on April 9, 2008. In her essay, Sara speaks of the joy that the birth of Ella has brought her:

"I'm so glad I listened to my dad's advice all those years ago. And with that, I say to all the desperate want-to-be mothers out there -- seek your own joy -- wherever and however that may be. Listen to the depths of you to guide you to where you find that joy. I found my joy. I felt it as I rocked my baby girl to sleep last night."

"We at RMIA are so happy to have contributed to Sara and Michael's dream of becoming parents," said Jacques Stassart, MD, director of IVF services. "IVF can be a long and challenging process for some couples, however, the end result is always worth all of the hard work. In Sara and Michael's case, it's a beautiful baby girl and a substantial start to her college education. We are proud to be a part of Sara's 'little miracle.'"

Other Winners

Runner-up Amy Crider of Jacksonville, FL, will receive $2,500 for an education fund for her five-month-old daughter, Reece. Ten honorable mention winners from around the country will each receive a $500 education fund.


MENOPUR and BRAVELLE are not indicated in women with ovarian failure, uncontrolled thyroid and adrenal dysfunction, pituitary or hormone dependent tumor, abnormal uterine bleeding of undetermined origin, or ovarian cysts or enlargement not due to polycystic ovary syndrome. Like all gonadotropins, these are potent substances capable of causing mild to severe adverse reactions, including Ovarian Hyper Stimulation Syndrome (OHSS), with or without pulmonary or vascular complications, in women undergoing therapy for infertility. Only physicians thoroughly familiar with infertility treatment, including the risk of multiple births and adverse reactions, should prescribe these medications. Like other products for ovarian stimulation, treatment with MENOPUR and/or BRAVELLE may result in multiple births.

About Ferring Pharmaceuticals

Ferring Pharmaceuticals, part of the Ferring Group, a privately owned, international pharmaceutical company, manufactures and markets the largest family of fertility treatments in the U.S. The Company markets MENOPUR, BRAVELLE, REPRONEX(R) (menotropins for injection, USP), NOVAREL(R) (chorionic gonadotropin for injection, USP) and ENDOMETRIN(R) (progesterone) Vaginal Insert 100 mg in the U.S. to infertility specialists and their patients. Ferring also offers the Q-CAP(TM), the first and only needle-free reconstitution device, for use with its fertility treatments.

Ferring's line of orthopaedic and urology products includes EUFLEXXA(R) (1% sodium hyaluronate) hyaluronic acid for pain from osteoarthritis in the knee and PROSED(R)/DS for the relief of discomfort of the lower urinary tract. Other products include: ACTHREL(R) (corticorelin ovine triflutate for injection) for the differential diagnosis of Cushing's syndrome; and DESMOPRESSIN ACETATE in injectable and rhinal tube forms for the treatment of diabetes insipidus and primary nocturnal enuresis.

The Ferring Group specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, gastroenterology, obstetrics/ gynecology, infertility and orthopaedics. For more information, call 888-337-7464 or visit or

Please contact Chris Stroup for full prescribing information for MENOPUR and BRAVELLE.


Christine Stroup

Kovak-Likly Communications

(203) 762-8833 or

SOURCE Ferring Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Smart Medical Technology, Inc. Awarded Novation Contract for Ground-breaking Liftaem(TM) System that Aids Lifting and Transferring Patients
2. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
3. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
4. Ferring Initial Purchase Order and Guaranteed Letter of Credit Launches Five Year Contract
5. Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2008 Winners Announced
6. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
7. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
8. Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry
9. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
10. Clinimetrics Celebrates 20th Anniversary in Contract Research Business
11. Guava Technologies Celebrates Tenth Anniversary
Post Your Comments:
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in ... 8:30aET on RFD-TV. , With global population estimates nearing ten billion people by ... feed a growing nation. At the same time, many of our valuable resources are ...
(Date:10/7/2017)... ... October 06, 2017 , ... With ... microscopy and surface analysis, Nanoscience Instruments is now expanding into Analytical Services. ... range of contract analysis services for advanced applications. Services will leverage techniques ...
Breaking Biology Technology:
(Date:4/19/2017)... , April 19, 2017 The ... vendor landscape is marked by the presence of several ... however held by five major players - 3M Cogent, ... companies accounted for nearly 61% of the global military ... companies in the global military biometrics market boast global ...
(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
Breaking Biology News(10 mins):